InnovaRx Innova Health Strategies

F18.21

Inhalant dependence, in remission

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 3 never code together
F18.2code
Excludes1
  • inhalant abuse (F18.1-)F18.1-
  • inhalant use, unspecified (F18.9-)F18.9-
F01-F99chapter
Excludes2
  • symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)R00-R99

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 6
F18code
Includes
  • volatile solvents
F18.21code
Inclusion terms
  • Inhalant use disorder, moderate, in early remission
  • Inhalant use disorder, moderate, in sustained remission
  • Inhalant use disorder, severe, in early remission
  • Inhalant use disorder, severe, in sustained remission
F01-F99chapter
Includes
  • disorders of psychological development
Index entries leading here 2
  • Dependence (on) (syndrome) F19.20
  • Disorder (of) — see also Disease
    • inhalant use
      • moderate or severe F18.20
        • in remission (early) (sustained) F18.21
Alongside this code 7 same parent — F18.2
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC55 CMS28HCC137 ESRD21HCC55 ESRD24HCC55

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
F18.2
Block
F10-F19
Siblings
7

Present FY2024–FY2027.